Insight Enterprises Inc. (NSIT) Drops 5.39% on February 11

Equities Staff |

Insight Enterprises Inc. (NSIT) was one of the Russell 2000's biggest losers for Thursday February 11 as the stock slid 5.39% to $21.68, a loss of $-1.235 per share. Starting at an opening price of $21.26 a share, the stock traded between $18.26 and $22.32 over the course of the trading day. Volume was 174,309 shares over 2,177 trades, against an average daily volume of 145,724 shares and a total float of 37.09 million.

The losses send Insight Enterprises Inc. down to a market cap of $804 million. In the last year, Insight Enterprises Inc. has traded between $32.80 and $21.14, and its 50-day SMA is currently $24.42 and 200-day SMA is $26.77.

The stock has a P/E Ratio of 11.6.

Insight Enterprises Inc is a provider of information technology ('IT') solutions to businesses and public sector institutions. The Company offers integrated solutions to the clients through its hardware, software, and services.

Insight Enterprises Inc. is based out of Tempe, AZ and has some 5,406 employees. Its CEO is .

For a complete fundamental analysis analysis of Insight Enterprises Inc., check out Equities.com’s Stock Valuation Analysis report for NSIT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…